Clorox (NYSE:CLX) Shares Unloaded Rep. Lisa C. McClain

Representative Lisa C. McClain (R-Michigan) recently sold shares of The Clorox Company (NYSE:CLX). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Clorox stock on October 30th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Clorox Stock Up 0.8%

NYSE CLX traded up $0.88 on Thursday, hitting $107.75. 1,632,970 shares of the stock traded hands, compared to its average volume of 1,753,730. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a 50-day moving average of $114.23 and a 200 day moving average of $121.67. The Clorox Company has a twelve month low of $98.20 and a twelve month high of $171.37. The company has a market capitalization of $13.14 billion, a P/E ratio of 16.53, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business’s quarterly revenue was down 18.9% on a year-over-year basis. During the same period in the previous year, the business earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be issued a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.6%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s payout ratio is currently 77.86%.

Insider Activity

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction on Friday, November 21st. The stock was bought at an average cost of $104.13 per share, with a total value of $416,520.00. Following the acquisition, the director owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.63% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on CLX shares. Jefferies Financial Group reissued a “buy” rating and set a $152.00 target price on shares of Clorox in a report on Tuesday, November 4th. BNP Paribas Exane dropped their price objective on shares of Clorox from $110.00 to $103.00 and set an “underperform” rating on the stock in a research note on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft decreased their target price on Clorox from $128.00 to $121.00 and set a “hold” rating for the company in a research note on Tuesday, November 4th. Barclays dropped their price target on Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a research report on Tuesday, November 4th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 14th. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have assigned a Sell rating to the company’s stock. According to MarketBeat, Clorox presently has an average rating of “Reduce” and an average price target of $125.69.

Institutional Trading of Clorox

A number of institutional investors have recently made changes to their positions in CLX. Horizon Investments LLC increased its stake in shares of Clorox by 4.4% during the first quarter. Horizon Investments LLC now owns 1,768 shares of the company’s stock valued at $258,000 after acquiring an additional 75 shares during the period. Sfmg LLC boosted its stake in Clorox by 2.8% during the 1st quarter. Sfmg LLC now owns 2,780 shares of the company’s stock valued at $409,000 after purchasing an additional 76 shares in the last quarter. Hancock Whitney Corp boosted its stake in Clorox by 4.3% during the 1st quarter. Hancock Whitney Corp now owns 2,064 shares of the company’s stock valued at $304,000 after purchasing an additional 86 shares in the last quarter. Brown Lisle Cummings Inc. increased its position in shares of Clorox by 4.3% during the 2nd quarter. Brown Lisle Cummings Inc. now owns 2,136 shares of the company’s stock valued at $256,000 after purchasing an additional 89 shares during the period. Finally, American National Bank & Trust raised its stake in shares of Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after buying an additional 89 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.